Email bulletins

Archive

December 2015

  • Access to hepatitis C treatment in Europe
  • Treatment costs
  • Cost of generic direct-acting antivirals
  • Coffee and liver fibrosis
  • Liver transplant waiting list reductions
  • Shortening treatment time
  • Is this your copy of the infohep news bulletin?

November 2015

  • News from The Liver Meeting 2015, San Francisco
  • Access to hepatitis C treatment in the United States: doctors and federal government urge wider access
  • Long-term outcomes after hepatitis C treatment: liver cancer
  • Long-term outcomes after hepatitis C treatment: reversal of liver damage
  • Hepatitis C treatment for people who inject drugs
  • Treatment for genotype 3
  • New drugs: pan-genotypic treatment combinations
  • Daclatasvir licensed to Medicines Patent Pool
  • Sofosbuvir and bradycardia
  • World Hepatitis Summit report and resources
  • New hepatitis C treatment factsheet
  • Is this your copy of the infohep news bulletin?

October 2015

  • US guidelines updated to recommend hepatitis C treatment for all
  • US Food and Drug Administration warning on Viekira Pak and Technivie
  • Hepatitis C treatment and prevention in people who inject drugs
  • Consensus definition for late presentation of viral hepatitis in Europe
  • Hepatic encephalopathy
  • Is this your copy of the infohep news bulletin?

September 2015

  • World Hepatitis Summit 2015
  • Gilead releases preliminary results on new pan-genotypic combination
  • Hepatitis C and heart disease
  • Daklinza approval for genotype 3 in European Union
  • Interferon-free treatment for people with HIV and HCV co-infection
  • The 24th International Harm Reduction Conference
  • Is this your copy of the infohep news bulletin?

July 2015

  • Hepatitis C in sub-Saharan Africa
  • Ribavirin
  • AbbVie reports on long-term post-cure outcomes of hepatitis C treatment
  • UK treatment access
  • Liver transplantation in HIV and hepatitis C co-infection
  • New booklets from the London Joint Working Group on Substance Use & Hepatitis C and Dr Harris, LSHTM
  • Is this your copy of the infohep news bulletin?

June 2015

  • More news from the International Liver Congress 2015
  • Hepatitis B news
  • Hepatitis delta
  • Statins and cirrhosis
  • Hepatitis C and cancer
  • Hepatitis C treatment
  • Access to treatment
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

May 2015

  • News from the International Liver Congress 2015
  • Hepatitis C special population: Chronic kidney disease
  • Treatment-experienced people
  • Decompensated cirrhosis, advanced cirrhosis and transplant patients
  • Genotype 3
  • Previously untreated people
  • EASL guidelines on treatment of hepatitis C
  • When to treat and liver damage in undiagnosed people
  • Alcohol and liver disease in people with hepatitis C
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

March 2015

  • World Health Organization hepatitis B treatment guidelines
  • Risks of delaying HCV treatment in HIV/HCV co-infection
  • Interferon-free treatment for HIV/HCV co-infection
  • Adherence to hepatitis C treatment
  • Sofosbuvir access
  • UNITAID
  • Harvoni recommended for genotypes 1 and 4 in England
  • 24th International Harm Reduction Conference – call for papers
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

February 2015

  • Hepatitis B treatment
  • Cost of hepatitis C treatment
  • Activist guide to treatment access
  • UNITAID guide to detection and monitoring of hepatitis C
  • Merck delay
  • 24th International Harm Reduction Conference – call for papers
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

January 2015

  • European approval for AbbVie interferon-free combination
  • Cost of treatment
  • Hepatitis C treatment availability: United Kingdom
  • India: Sofosbuvir patent rejected
  • Hepatitis C treatment for people after liver transplant
  • Hepatitis C drugs in development
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?